DoW Ovarian Cancer, Clinical Trial Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- May 4, 2026
- Amount
- Program total $5.6M
- Closes
- Oct 1, 2026 (in 14 days)
Similar opportunities open now
- DoW, Ovarian Cancer, Investigator-Initiated Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 14 days
- DoW, Ovarian Cancer, Pilot AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 14 days
- DoW, Ovarian Cancer, Ovarian Cancer Academy – Early-Career Investigator AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 14 days
- DoW Peer Reviewed Cancer, Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 18 days
- DoW Autism Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 35 days
Classification and identifiers
- Solicitation number
- HT942526OCRPCTA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $5.6M
Who can apply
About this opportunity
Summary: The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer. Distinctive Features: Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations.